The CNCR focuses on the mechanistic understanding of gene function in the context of cognitive function.
We provide Neuroscience research training programs at Bachelor, Master, PhD and Postdoc levels
Upcoming seminars, mark your agenda!
Research team led by Ronald van Kesteren receives 675 k€ to investigate changes in brain activity that can provide new diagnostic markers or treatment targets for early-stage Alzheimer’s disease.
Dr. Rik van der Kant (CNCR-FGA) and colleagues report that accumulation of cholesterol in Alzheimer’s disease neurons drives early Tau- and Amyloid pathology, and can be reversed by cholesterol-targeting drugs. Published in Cell Stem Cell.
Postdocs Iris Jansen, Jeanne Savage and others from CNCR-CTG find novel genetic risk factors for Alzheimer’s dementia, published in Nature Genetics